CLINUVEL expands DNA Repair Program
23 mars 2021 20h10 HE
|
Clinuvel Pharmaceuticals Limited
SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) MELBOURNE, Australia, March 24, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its clinical program to...